Veraxa Biotech AG Ordinary Shares (VRXA) is a publicly traded the market company. As of July 28, 2026, VRXA trades at $2.15 with a market cap of $254.53M and a P/E ratio of 0.00. VRXA moved +22.22% today. Year to date, VRXA is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $1.70 to $27.36. Rallies surfaces VRXA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Veraxa Biotech AG Ordinary Shares (VRXA) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. VRXA moved +22.22% today.
| Metric | Value |
|---|---|
| Price | $2.15 |
| Market Cap | $254.53M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $27.36 |
| 52-Week Low | $1.70 |
| Volume | 290.73K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
VRXA analyst coverage data. Average price target: $0.00.